JP2023553694A5 - - Google Patents

Info

Publication number
JP2023553694A5
JP2023553694A5 JP2023536863A JP2023536863A JP2023553694A5 JP 2023553694 A5 JP2023553694 A5 JP 2023553694A5 JP 2023536863 A JP2023536863 A JP 2023536863A JP 2023536863 A JP2023536863 A JP 2023536863A JP 2023553694 A5 JP2023553694 A5 JP 2023553694A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
polypeptide
acid sequence
isvd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023536863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553694A (ja
JP7842101B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/086595 external-priority patent/WO2022129572A1/en
Publication of JP2023553694A publication Critical patent/JP2023553694A/ja
Publication of JP2023553694A5 publication Critical patent/JP2023553694A5/ja
Application granted granted Critical
Publication of JP7842101B2 publication Critical patent/JP7842101B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023536863A 2020-12-18 2021-12-17 IL-6およびTNF-αを標的化する免疫グロブリン単一可変ドメインを含むポリペプチド Active JP7842101B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20306612.1 2020-12-18
EP20306612 2020-12-18
US202163167925P 2021-03-30 2021-03-30
US63/167,925 2021-03-30
PCT/EP2021/086595 WO2022129572A1 (en) 2020-12-18 2021-12-17 Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha

Publications (3)

Publication Number Publication Date
JP2023553694A JP2023553694A (ja) 2023-12-25
JP2023553694A5 true JP2023553694A5 (https=) 2024-10-25
JP7842101B2 JP7842101B2 (ja) 2026-04-07

Family

ID=79185795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536863A Active JP7842101B2 (ja) 2020-12-18 2021-12-17 IL-6およびTNF-αを標的化する免疫グロブリン単一可変ドメインを含むポリペプチド

Country Status (6)

Country Link
US (2) US11897951B2 (https=)
EP (1) EP4263602A1 (https=)
JP (1) JP7842101B2 (https=)
KR (1) KR20230123497A (https=)
TW (1) TW202239763A (https=)
WO (1) WO2022129572A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL318433A (en) 2014-05-16 2025-03-01 Ablynx Nv Improved immunoglobulin variable complexes
EP4707303A2 (en) 2014-05-16 2026-03-11 Ablynx NV Improved immunoglobulin variable domains
AR131494A1 (es) 2022-12-23 2025-03-26 Ablynx Nv Vehículos de conjugación a base de proteína
TW202448926A (zh) 2023-02-17 2024-12-16 比利時商艾伯霖克斯公司 結合新生兒fc受體之多肽
WO2025056575A1 (en) 2023-09-11 2025-03-20 Novo Nordisk A/S Anti il-6 domain antibodies
WO2026047197A1 (en) 2024-08-30 2026-03-05 Sanofi Biotechnology Differential biomarkers for anti-interleukin-6 and anti-tumor necrosis factor-α treatment response in rheumatoid arthritis

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750106T3 (de) 1986-08-06 1999-04-22 Ajinomoto Co., Inc., Tokio/Tokyo Rekombinanter B-Zell-Differenzierungsfaktor.
JP2598666B2 (ja) 1987-10-19 1997-04-09 忠三 岸本 抗ヒトbcdfモノクローナル抗体
CA1341152C (en) 1988-01-22 2000-12-12 Tadamitsu Kishimoto Receptor protein for human b cell stimulatory factor-2
ES2093017T3 (es) 1989-07-20 1996-12-16 Tadamitsu Kishimoto Anticuerpo contra el receptor de la interleuquina-6 humana.
JP2898064B2 (ja) 1989-08-03 1999-05-31 忠三 岸本 ヒトgp130蛋白質
JPH05304986A (ja) 1992-04-28 1993-11-19 Tosoh Corp gp130蛋白質に対するモノクロ−ナル抗体
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
ES2162863T3 (es) 1993-04-29 2002-01-16 Unilever Nv Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
ES2294799T3 (es) 1996-06-27 2008-04-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Moleculas de anticuerpos que interactuan especificamente con el sitio activo o hendidura de una molecula diana.
DK1027439T3 (da) 1997-10-27 2010-05-10 Bac Ip Bv Multivalente antigenbindende proteiner
AU3596599A (en) 1998-01-26 1999-08-09 Unilever Plc Method for producing antibody fragments
EP1141711A1 (en) 1999-01-05 2001-10-10 Unilever Plc Binding of antibody fragments to solid supports
DK1144616T4 (da) 1999-01-19 2009-03-30 Unilever Nv Fremgangsmåde til fremstilling af antistoffragmenter
CA2370351A1 (en) 1999-04-22 2000-11-02 Unilever Plc Inhibition of viral infection using monovalent antigen-binding proteins
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
WO2001040310A2 (en) 1999-11-29 2001-06-07 Unilever Plc Immobilisation of proteins using a polypeptide segment
ES2331051T3 (es) 1999-11-29 2009-12-21 Bac Ip B.V. Inmovilizacion de moleculas de union de antigenos de un dominio.
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US20030190598A1 (en) 2000-05-26 2003-10-09 Jasmid Tanha Single-domain antigen-binding antibody fragments derived from llama antibodies
ATE513854T1 (de) 2000-12-13 2011-07-15 Bac Ip B V Proteinraster aus variablen domänen der schweren immunoglobulinkette von kamelen
JP4213586B2 (ja) 2001-09-13 2009-01-21 株式会社抗体研究所 ラクダ抗体ライブラリーの作製方法
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
EP1456410A2 (en) 2001-12-11 2004-09-15 AlgoNomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
EP1456237A2 (en) 2001-12-21 2004-09-15 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Method for cloning of variable domain sequences
CA2471645A1 (en) 2002-01-03 2003-07-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Immunoconjugates useful for treatment of tumours
WO2004041863A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against interferon- gamma and uses therefor
EP1558645B1 (en) 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
JP2006517789A (ja) 2003-01-10 2006-08-03 アブリンクス エン.ヴェー. 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
ATE485307T1 (de) 2003-11-07 2010-11-15 Ablynx Nv Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
WO2006040153A2 (en) 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
AU2005325801A1 (en) 2005-01-31 2006-08-03 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
US8188223B2 (en) 2005-05-18 2012-05-29 Ablynx N.V. Serum albumin binding proteins
ES2694247T3 (es) 2005-05-20 2018-12-19 Ablynx N.V. NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
US20110059101A9 (en) * 2006-03-13 2011-03-10 Ablynx N.V. Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
AU2007237501A1 (en) 2006-04-14 2007-10-25 Ablynx N.V. DP-78-like nanobodies
WO2008020079A1 (en) 2006-08-18 2008-02-21 Ablynx N.V. Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
EP2723771B1 (en) 2011-06-23 2019-09-11 Ablynx NV Serum albumin binding proteins
SG10201805064SA (en) 2011-06-23 2018-07-30 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
EP4707303A2 (en) 2014-05-16 2026-03-11 Ablynx NV Improved immunoglobulin variable domains
EP3365371B1 (en) 2015-10-22 2025-10-08 Ablynx NV Gitr agonists
NO2768984T3 (https=) * 2015-11-12 2018-06-09
LT3374392T (lt) 2015-11-13 2022-01-25 Ablynx Nv Patobulinti serumo albuminą surišantys imunoglobulino kintami domenai
AU2016357460B2 (en) 2015-11-18 2023-07-27 Ablynx Nv Improved serum albumin binders
EP3202788A1 (en) 2016-02-05 2017-08-09 MediaPharma S.r.l. Endosialin-binding antibody
RU2022101604A (ru) 2016-12-07 2022-03-29 Аблинкс Нв Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином
WO2018131234A1 (ja) 2017-01-16 2018-07-19 株式会社村田製作所 ピエゾ抵抗素子、力学量検知センサおよびマイクロフォン
JP7219220B2 (ja) * 2017-01-17 2023-02-07 アブリンクス エン.ヴェー. 改善された血清アルブミン結合剤
IL267897B2 (en) 2017-01-17 2025-02-01 Ablynx Nv Improved serum albumin binders

Similar Documents

Publication Publication Date Title
JP2023553694A5 (https=)
JP7453206B2 (ja) 改良された血清アルブミン結合剤
JP2023504914A5 (https=)
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2024063213A5 (https=)
JP2023085476A5 (https=)
JP2023505492A5 (https=)
JP2022526595A5 (https=)
KR102641194B1 (ko) 개선된 tnf 결합제
JP2018537421A5 (https=)
JP2020195399A5 (https=)
JP2020500510A5 (https=)
JP2023553697A5 (https=)
JP2011523550A5 (https=)
TW201031421A (en) IL-1 binding proteins
KR20030034140A (ko) 인간 IL-1β에 대한 항체
JP2025512865A5 (https=)
WO2016048188A1 (ru) Высокоаффиные и агрегационно стабильные антитела на основе вариабельных доменов vl и производного vhh
JP2017519503A5 (https=)
JP2025530888A5 (https=)
CN116478278B (zh) 中性抗体
JP2022521956A5 (https=)
JP2024504923A5 (https=)
JP2024023268A5 (https=)
WO2015027906A1 (zh) 双功能融合蛋白及其制备方法和用途